Searched for
ARV DEAL
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Rafale, SCALP get DAC nod; Meteor missile next? How India is planning to make 'Op Sindoor hero' a mighty fighterThe Defence Acquisition Council is set to review significant procurement proposals, including the acquisition of 114 Rafale combat aircraft...
- Kotak Alternate Asset Managers invests Rs 1,445 cr to help Matrix Pharma execute acquisitionKotak Alternate Asset Managers Ltd invested Rs 1,445 crore in Matrix Pharma for acquiring Vaitris' API business, making Matrix the 2nd larg...
- Matrix Laboratories founder buys back API Biz from ViatrisNimmagadda Prasad, the founder of Matrix Laboratories, has bought back the active pharmaceutical ingredients (API) business he sold to Myla...
- Viatris puts India API business on the blockHowever, the API sale process, which was launched a couple of months ago, has seen no serious buyers, added multiple people aware of the de...
- Ineffective Vaccines Not Cause of Rabies deaths in Kerala: Central teamDeaths have also been attributed to improper wound washing facilities at animal bite management facilities even at tertiary care level and ...
- Reliance Retail close to signing up as Gap Franchisee in IndiaArvind Fashions failed to turn Gap's business in India profitable even after closing and pruning store sizes and increasing local sourcing ...
- Moving West? Shah Rukh Khan invited to star in BBC drama 'Dirk Gently's Holistic Detective Agency'The actor was quick to respond to the invitations saying, "Let me know the time and place."
- Laurus Labs fixes IPO price band at Rs 426-428 a piece; issue opens on Dec 6The issue consists of an offer for sale (OFS) of 24,107,440 equity shares by existing shareholders Aptuit, Bluewater, FIL Capital Managemen...
- Having a debate will be a good starting point for HIV billHIV & AIDS (Prevention and Control) Bill, 2014 is also one of the few bills drafted with inputs from all stakeholders, particularly from th...
- CCI rules out case against Gilead SciencesCCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.
- Hot Stock: Citi expects Aurobindo Pharma to rally 20%Citi has maintained ‘buy’ recommendation on Aurobindo Pharma and raised its target price to Rs 210.
- Flaws in contract terms stall $275-mn ARV dealThe $275 million armoured recovery vehicle deal has run into fresh trouble relating to specification mismatch that has been red-flagged by ...
- CBI probe finds India biggest buyer of Tatra trucksThe CBI probe into Tatra trucks procurement scam has almost established that India is the biggest buyer of T-815 trucks.
- Now, CBI to probe BEML’s ARV deal with ArmyAfter Tatra trucks, the Central Bureau of Investigation (CBI) is focusing on the procurement of armoured recovery vehicles (ARV) WZT-3 to t...
- Mylan Laboratories looks for partners to launch drugsMatrix Laboratories, which was acquired by Mylan , is exploring new partnerships in India to launch about 100 products.
- Court allows Sanjeev Nanda to travel abroadSanjeev Nanda, son of arms dealer Suresh Nanda and prime accused in BMW-hit-and-run case, would soon be flying out of the country as a Delh...
- Strides Arcolab gets US nod for anti-HIV drugPharmaceutical company, Strides Arcolab has received tentative approval from the United States Food and Drug Administration (USFDA) for Efa...
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.
- Mylan to span out to Europe, AfricaThe $1.2-bn US-based Mylan Labs may just have captured value across the chain with the Matrix deal.
Load More
